NTG Shockproof Designed for iPhone 11 Case [2 Layer Structure Protection] [Military Grade Anti-Drop] Lightweight Shockproof Protective Phone Case for iPhone 11 6.1 inch, Red

Product Information

Endothelial dysfunction plays a key role in atherosclerotic disease. Several methods have been reported to be useful for evaluating endothelial dysfunction. Igari et al. demonstrated that the endothelial function measured by peripheral arterial tonometry significantly correlated with the ABI in patients with PAD, and they investigated endothelial dysfunction in patients with PAD [ 37]. Because the diagnosis of PAD was confirmed in our patient with NTG, we believe that endothelial dysfunction secondary to PAD could be a probable risk factor for and pathological cause of optic nerve damage in our patient’s case, although this probable effect should be confirmed in future studies. Von Graefe, A. Iridectomie bei Glaucom and ueber den glaucomatosen Pozess. Graefe’s Arch. Clin. Exp. Ophthalmol. 1857, 3, 456–650. [ Google Scholar] [ CrossRef] Polak K, Luksch A, Frank B, Jandrasits K, Polska E, Schmetterer L. Regulation of human retinal blood flow by endothelin-1. Exp Eye Res. 2003;76(5):633–40.

Sakata, R.; Yoshitomi, T.; Iwase, A.; Matsumoto, C.; Higashide, T.; Shirakashi, M.; Aihara, M.; Sugiyama, K.; Araie, M.; Lower Normal Pressure Glaucoma Study Members in Japan Glaucoma Society. Factors Associated with Progression of Japanese Open-Angle Glaucoma with Lower Normal Intraocular Pressure. Ophthalmology 2019, 126, 1107–1116. [ Google Scholar] [ CrossRef] [ PubMed]Grieshaber MC, Terhorst T, Flammer J. The pathogenesis of optic disc splinter haemorrhages: a new hypothesis. Acta Ophthalmol Scand. 2006;84(1):62–8.

The aim of the study was to determine the frequency of pathologies which can mimic normal-tension glaucoma, observed in the neuroimaging of NTG patients, and to evaluate the frequency of pathologies in each of the additional indications for neuroimaging. 2. Material and Methods Yang, Y.; Sun, X. Retinal Ganglion Cell Death in Glaucoma: Advances and Caveats. Curr. Eye Res. 2023, 48, 1–10. [ Google Scholar] [ CrossRef]

Zhang, Y.; Bian, A.; Hang, Q.; Li, L.; Zhang, S.; Cheng, G.; Zhou, Q. Corneal Biomechanical Properties of various types of glaucoma and their impact on measurement of intraocular pressure. Ophthalmic Res. 2023, 66, 742–749. [ Google Scholar] [ CrossRef] Islam, S.; Spry, C. Prostaglandin Analogues for Ophthalmic Use: A Review of Comparative Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet]; Canadian Agency for Drugs and Technologies in Health: Ottawa, ON, Canada, 2020. [ Google Scholar] Baek, S.U.; Ha, A.; Kim, D.W.; Jeoung, J.W.; Park, K.H.; Kim, Y.K. Risk factors for disease progression in low-teens normal-tension glaucoma. Br. J. Ophthalmol. 2020, 104, 81–86. [ Google Scholar] [ CrossRef] [ PubMed] Dinakaran, S.; Mehta, P.; Mehta, R.; Tilva, B.; Arora, D.; Tejwani, S. Significance of non-intraocular pressure (IOP)-related factors particularly in normal tension glaucoma: Looking beyond IOP. Indian J. Ophthalmol. 2022, 70, 569–573. [ Google Scholar] [ CrossRef] Keppel Hesselink, J.M.; Costagliola, C.; Fakhry, J.; Kopsky, D.J. Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy. J. Ophthalmol. 2015, 2015, 430596. [ Google Scholar] [ CrossRef] [ PubMed]